Loading...
Loading...
Synergy Pharmaceuticals Inc
SGYP shares dipped 4.7% to $3.94 after the company reported positive trial update with dolcanatide in patients with ulcerative colitis. Share volume totaled 1.3 million, compared to an all-day average of two million
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
